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Convergence of the Fanconi Anemia and
Ataxia Telangiectasia Signaling Pathways
The six cloned FA proteins (A, C, D2, E, F, and G)
interact in a common pathway. Five of the proteins (A, C,
E, F, and G) assemble in a multisubunit nuclear complex
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nated and targeted to BRCA1 nuclear foci (Garcia-Children’s Hospital
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(Gluckman et al., 1983; Marcou et al., 2001). Second,
some immortalized FA lymphoblasts appear to be hy-Summary
persensitive to IR (Bigelow et al., 1979; Knox et al., 1981;
Parshad et al., 1983) and to the radiomimetic drug bleo-Fanconi anemia (FA) and ataxia telangiectasia (AT) are
mycin (Carreau et al., 1999). Third, the single-cell gelclinically distinct autosomal recessive disorders char-
electrophoresis (comet) assay reveals a high DNA dam-acterized by spontaneous chromosome breakage and
age rate in FA cells following IR exposure (Djuzenovahematological cancers. FA cells are hypersensitive to
et al., 2001). However, other studies have not detectedmitomycin C (MMC), while AT cells are hypersensitive
IR sensitivity of FA cells (Duckworth-Rysiecki and Tay-to ionizing radiation (IR). Here, we identify the Fanconi
lor, 1985), although these reports may result from theanemia protein, FANCD2, as a link between the FA and
use of cells from different FA complementation groups.ATM damage response pathways. ATM phosphory-
Taken together, at least some FA subtypes appear tolates FANCD2 on serine 222 in vitro. This site is also
have an underlying IR sensitivity, similar to other humanphosphorylated in vivo in an ATM-dependent manner
diseases including ataxia telangiectasia (AT; Kastan etfollowing IR. Phosphorylation of FANCD2 is required
al., 1992), Nijmegen breakage syndrome (NBS; Carney etfor activation of an S phase checkpoint. The ATM-
al., 1998), and ataxia telangiectasia-like disorder (ATLD;dependent phosphorylation of FANCD2 on S222 and
Stewart et al., 1999).the FA pathway-dependent monoubiquitination of
AT is another autosomal recessive human disease,FANCD2 on K561 are independent posttranslational
which results in spontaneous chromosome breakagemodifications regulating discrete cellular signaling
and hematological cancers (Khanna et al., 1999). Unlikepathways. Biallelic disruption of FANCD2 results in
FA patients, AT patients have immunodeficiency andboth MMC and IR hypersensitivity.
progressive cerebellar neural degeneration. AT cells are
hypersensitive to IR, but are not hypersensitive to cross-
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linking agents. The ATM (ataxia telangiectasia mutated)
gene encodes an IR-activated protein kinase, which
Fanconi anemia (FA) is an autosomal recessive chromo- phosphorylates and activates proteins involved in cell
some instability disorder characterized by develop- cycle checkpoint responses, including p53 (Banin et al.,
mental defects, progressive bone marrow failure, and 1998; Canman et al., 1998), CHK2 (Matsuoka et al., 1998),
cancer susceptibility (Joenje and Patel, 2001; Grompe Nbs1 (Lim et al., 2000; Zhao et al., 2000; Wu et al., 2000b;
and D’Andrea, 2001). FA patients develop primarily he- Gatei et al., 2000), and BRCA1 (Cortez et al., 1999). Many
matological cancers but also develop squamous cell of these checkpoint proteins, including Nbs1, Mre11,
carcinomas (Alter, 1996). FA cells are sensitive to DNA and BRCA1 colocalize following IR (Wu et al., 2000a)
crosslinking agents, such as mitomycin C (MMC) and and cooperate in the IR-activated S phase checkpoint
diepoxybutane (DEB), suggesting a cellular defect in response (Xu et al., 2001). Biallelic loss of the ATM gene
DNA repair. Somatic cell fusion studies have defined or these ATM substrates results in a defect in the IR-
eight complementation groups (A, B, C, D1, D2, E, F, activated S phase checkpoint.
and G; Joenje et al., 1997; Timmers et al., 2001), and In the current study, we show that FA cells from sub-
six of the FA genes have been cloned (reviewed in Joenje type D2 (FANCD2 / cells) are sensitive to both MMC
and Patel, 2001; Grompe and D’Andrea, 2001). and IR and have a defect in the IR-inducible S phase
checkpoint response similar to that observed in AT cells.
When normal cells are exposed to IR, ATM phosphory-4 Correspondence: alan_dandrea@dfci.harvard.edu
5 These authors contributed equally to this work. lates FANCD2 on serine 222, thereby activating this
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Figure 1. FA-D2 Cells Are Defective in an IR-Inducible S Phase Checkpoint and Exhibit IR Sensitivity
(A) Replicative DNA synthesis was assessed 30 min after delivery of the various indicated doses of ionizing radiation to SV40 transformed
fibroblast lines. Cells analyzed were PD-20F (Fanconi anemia D2), PD-20F stably expressing FANCD2(wt), ATM (/) (AT22IJE-T) (Ziv et al.,
1997), and normal human fibroblasts (GM0637), as indicated.
(B) Mitomycin C sensitivity of the indicated fibroblasts.
(C) IR sensitivity of human FA-D2 and ATM (/) lymphoblast lines.
(D) Mitomycin C sensitivity of the indicated human lymphoblast lines. Data are representative of three independent experiments.
checkpoint response. Moreover, IR-activated phos- Results
phorylation of FANCD2 is mechanistically distinct and
independent of MMC-activated monoubiquitination. FA-D2 Cells Have a Defect in the IR-Inducible
S Phase CheckpointFANCD2 therefore functions at the intersection of two
signaling pathways, one involving IR activation by ATM Since AT and FA share some clinical and cellular phe-
notypes, we initially examined FA subtype D2 (FA-D2)and the other involving MMC activation by the FA com-
plex. The enzyme/substrate interaction of ATM and fibroblasts for function of the IR-inducible S phase
checkpoint (Figure 1). This checkpoint represents theFANCD2 accounts, at least in part, for the common clini-
cal and cellular phenotypes of AT and FA patients. inhibition of replicon initiation by DNA damage and is
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Figure 2. ATM Is Required for the IR-Induc-
ible Phosphorylation of the FANCD2 Protein
(A) The FA protein complex (ACEFG complex)
is required for monoubiquitination of
FANCD2. Whole- cell extracts from the indi-
cated human lymphoblasts were immu-
noblotted with an anti-FANCD2 antibody.
PD7 are normal human lymphoblasts. The
FA-A lymphoblasts and FA-G lymphoblasts
were stably transduced with either FANCA
(lane 3) or FANCG (lane 5).
(B) Mobility change of endogenous FANCD2
following IR treatment results from phosphor-
ylation. Extracts from GM0637 (wild-type fi-
broblast), 326SV (Fanconi anemia subtype G
fibroblast), and HeLa cells were immunoblot-
ted for FANCD2 using mAb FI17. Cells were
treated with or without 30 Gy of IR as indi-
cated, and after 2 hr, cells were collected.
In lanes 13–15, protein from irradiated HeLa
cells was treated  lambda-phosphatase
and  phosphatase inhibitors, as indicated,
and immunoblotted for FANCD2.
(C) Mobility shift of the FANCD2 isoforms
after 10 Gy irradiation of AT22IJE-T fibro-
blasts (Ziv et al., 1997) expressing either
empty vector (lanes 1–5) or full-length ATM
(lanes 6–10). Whole-cell extracts were immu-
noblotted with either anti-FANCD2 or anti-
Nbs1.
(D) AT (/) or ATM-corrected cells were ex-
posed to 10 Gy of IR, and immunofluores-
cence was performed with a rabbit polyclonal
anti-FANCD2 antiserum.
measured as a transient decrease in [3H]-thymidine in- rived from subtypes A, C, E, F, and G, indicating that
the FA protein complex (ACEFG complex) is requiredcorporation at early times (30–90 min) after irradiation
(Morgan et al., 1997). Interestingly, FA-D2 fibroblasts for monoubiquitination of FANCD2 (Figure 2A and data
not shown).displayed radioresistant DNA synthesis (RDS), therefore
exhibiting an S phase checkpoint defect similar to that We next tested whether the two isoforms of FANCD2
are further modified by phosphorylation (Figure 2B).observed in AT fibroblasts. Retroviral correction of FA-
D2 cells with wild-type FANCD2 restored the IR-induc- Both isoforms were present in normal fibroblasts and
HeLa cells (Figure 2B, lanes 1, 3, 9, and 11). IR upregu-ible S phase checkpoint (Figure 1A and Supplemental
Table S1 available at http://www.cell.com/cgi/content/ lated the cellular level of FANCD2-L and activated an
upward shift of both isoforms (lanes 2, 4, 10, and 12).full/109/4/459/DC1) and restored MMC resistance (Fig-
ure 1B). This upward shift is small, due to the large size of the
FANCD2 protein. The IR-activated upward shift of theIn addition, we examined EBV-transformed lympho-
blasts from the same FA-D2 patient for their IR and MMC two isoforms was reversed by treatment with lambda
phosphatase (lanes 13–15), indicating that IR activatessensitivity. FA-D2 lymphoblasts were hypersensitive to
IR (Figure 1C) and MMC (Figure 1D), and this sensitivity FANCD2 phosphorylation. In subtype FA-G cells (lanes
5–8), FANCD2 was not monoubiquitinated but was phos-was complemented by stable transfection with the
FANCD2 cDNA. ATM (/) lymphoblasts were more phorylated following IR (lanes 6 and 8). This phosphory-
lation of FANCD2 was confirmed later with anti-phos-sensitive to IR than FA-D2 cells, but were resistant to
MMC. phoserine activation-specific antibodies (Figure 5E,
below). These results indicate that monoubiquitination
of FANCD2 is not essential for IR-inducible phosphory-Ionizing Radiation Activates FANCD2
Phosphorylation lation.
The presence of RDS in both ATM (/) cells andWe have previously shown that the FANCD2 protein
exists as two isoforms, FANCD2-S (unubiquitinated) and FANCD2 (/) cells suggested that ATM may phosphor-
ylate FANCD2. To test this hypothesis, we examinedFANCD2-L (monoubiquitinated on K561; Garcia-Higuera
et al., 2001). FANCD2-L is not observed in FA cells de- the time course of IR-dependent phosphorylation of
Cell
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FANCD2 in ATM (/) cells versus isogenic ATM cDNA- We next examined phosphorylation of FANCD2 in vivo
corrected cells (Ziv et al., 1997; Figure 2C). IR activated (Figure 4). Initially, we generated the cDNA encoding
the phosphorylation of FANCD2 in the ATM-corrected an internally deleted mutant of FANCD2, referred to as
cells (i.e., both FANCD2-S and FANCD2-L shift upward FANCD2NcoI, lacking the monoubiquitination site (Fig-
in lanes 7–10), and phosphorylation correlated with the ure 4A) and transfected this cDNA into AT cells or wild-
increase in the FANCD2-L (monoubiquitinated) isoform. type cells. Phosphorylation of the encoded FANCD2 mu-
Similarly, IR activated the phosphorylation of p95/Nbs1 tant protein was evaluated by band shift. An upward
in ATM-corrected cells within 2 hr of treatment, as pre- shift of FANCD2NcoI after IR treatment was observed
viously described (Lim et al., 2000; Wu et al., 2000b; in wild-type cells, but not in AT cells (Figure 4B), and
Zhao et al., 2000; lanes 7–10). In contrast, IR failed to lambda phosphatase treatment revealed that this shift
activate the phosphorylation of FANCD2 or p95/Nbs1 was due to phosphorylation (Figure 4C).
(lanes 1–5) in ATM (/) cells, although FANCD2 mono- We used mass spectrometry to identify the in vivo
ubiquitination increased. IR-inducible FANCD2 foci also phosphorylation sites of FANCD2. We stably transfected
assembled in uncorrected and corrected AT cells (Fig- HeLa cells with the FANCD2NcoI cDNA, treated the
ure 2D and Supplemental Table S1 at above URL), indi- cells with IR, and purifed the internally truncated FANC-
cating that foci formation correlates with monoubiqui- D2NcoI protein by immunoprecipitation and SDS gel
tination but not phosphorylation of FANCD2. Taken electrophoresis. The purified protein was trypsinized,
together, these data suggest that ATM is required for the and the tryptic fragments were analyzed by ion trap
IR-dependent phosphorylation of FANCD2. IR-inducible mass spectrometry. Mass spectrometry confirmed S222
FANCD2 phosphorylation is not essential for either mono- as a site of phosphorylation in vivo (Figure 4D). A second
ubiquitination or foci formation. peptide was doubly phosphorylated in vivo, containing
phosphorylations at S1401, S1404, or S1418 (Figures
ATM Phosphorylates FANCD2 In Vitro and In Vivo 4E and 4F). These results are consistent with the ATM-
ATM phosphorylates serine or threonine residues within dependent phosphorylation sites observed in vitro (Fig-
the context of a defined consensus sequence, S/T-Q ure 3). We did not perform the mass spectrometry on
(Kim et al., 1999). Based on this consensus, the human FANCD2 extracted from unirradiated HeLa cells, and
FANCD2 protein has nineteen candidate ATM phosphor- therefore we could not determine whether these serine
ylation sites; the sites are S64, S178, S222, S319, T393, residues were constitutively phosphorylated or IR induc-
T596, T608, T691, S705, S717, S973, S1079, S1104, ibly phosphorylated. Instead, we used the phosphoser-
S1112, S1257, S1354, S1401, S1404, and S1418. A ine mapping information to generate anti-phosphoser-
preferred consensus sequence of ATM kinase has ine antisera.
also been identified (B(P/M/Y/F/G)-X-B(S/A/D/E)-S/T-Q),
where B indicates hydrophobic amino acids (Kim et al., Generation of Anti-Phosphoserine (Activation-
1999). Based on this consensus, human FANCD2 protein Specific) Antisera for FANCD2
has six preferred ATM phosphorylation sites (S178, To confirm the sites of in vivo phosphorylation of
S222, S319, T596, S705, and S1257). Of these sites, FANCD2 and to determine whether these sites are phos-
S222 and S1257 are conserved between human and
phorylated in an IR-inducible manner, we generated two
murine FANCD2 (M. Grompe, personal communication),
anti-phosphoserine-specific antisera, one directed
thereby identifying these sites as the strongest candi-
against phosphoserine222 (anti-pSer222) and the otherdates for ATM phosphorylation.
directed against phosphoserine1404 (anti-pSer1404;To demonstrate the direct role of ATM in the phos-
Figure 5). We chose S1404 since it contains the bestphorylation of these FANCD2 amino acid residues, we
ATM consensus among the S1401, S1404, and S1418generated GST fusion proteins containing variable re-
sites. Using these antisera, we immunoblotted whole-gions of FANCD2 (Figure 3A). Two GST fusion proteins,
cell lysates from FA-D2 cells stably expressing eitherGST-FANCD2 (2-272) and GST-FANCD2 (1186-1451),
wild-type FANCD2, a FANCD2-S222A mutant, a FANCD2containing either S222 or S1257, were phosphorylated
triple mutant (S1401A, S1404A, S1418A), or a FANCD2by ATM kinase in vitro (Figure 3B), further suggesting
quadruple mutant (S222A, S1401A, S1404A, S1418A;that these serine residues may be the relevant targets
Figure 5A).of ATM phosphorylation in vivo.
Following cellular exposure to IR, the anti-pSer222The possible in vitro phosphorylation of S222 and
antibody detected the FANCD2(wt) and FANCD2(tripleS1257 was further examined by generation of serine
mutant), but not the FANCD2-S222A or FANCD2(qua-to alanine mutations (Figure 3C). An S222A mutation
druple mutant). Both isoforms of FANCD2 (-S and -L)reduced the phosphorylation of GST-FANCD2 (2-272)
were immunoreactive with the antisera. FANCD2-Sand GST-FANCD2 (190-249) (Figure 3C, lanes 8 and 12).
generates a stronger signal on the immunoblot thanThe relatively low level of phosphorylation of the larger
FANCD2-L, perhaps due to the relative overexpressionGST-FANCD2 (2-272) fusion protein, compared to the
of FANCD2-S in these transfected cells. In contrast, theGST-FANCD2 (190-249) fusion, may result from misfold-
anti-pSer1404 antibody detected only the FANCD2(wt)ing of the larger fusion product. An S1257A mutation
and FANCD2-S222A mutant. These results indicate thathad no effect on the phosphorylation of GST-FANCD2
(1) IR activates the phosphorylation of both S222 and(1186-1451; data not shown). A triple mutant (S1401A-
S1404 in vivo and (2) the antisera are specific reagentsS1404A-S1418A) showed a reduction of phosphoryla-
for these phosphorylation sites.tion (Figure 3C, lane 16). These results suggest that S222
We focused our subsequent experiments exclusivelyand either S1401, S1404, or S1408 are sites of ATM-
dependent phosphorylation in vitro. on phosphoryation of S222, since S222 is conserved in
Interaction of ATM and FANCD2
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Figure 3. In Vitro Kinase Activity of ATM with GST-FANCD2 Fusion Proteins as Substrates
(A) GST fusion proteins containing the indicated region of the FANCD2 protein were generated, purified, and used as substrates in in vitro
kinase assays with either wild-type or kinase-dead ATM. The serine residues that were subsequently mutated to alanine are shown.
(B) In vitro phosphorylation of the different GST-FANCD2 fusion proteins by ATM kinase immunoprecipitated from either a normal lymphoblast
line (WT) or from AT lymphoblasts (AT). The amount of fusion protein in each reaction is shown in the lower panels. Unfused GST (lanes 1
and 2) and GST-p53 (Lim et al., 2000; lanes 3 and 4) were used as controls.
(C) GST-FANCD2 fusions containing the indicated FANCD2 sequence either unchanged or with the noted serine to alanine substitutions, were
used as substrates in an in vitro kinase assay with wild-type (WT) or kinase dead (KD). Flag-tagged ATM immunoprecipitated from transfected
293 T cells (Canman et al., 1998; Lim et al., 2000). The level of ATM kinase in each reaction was assessed by immunoblot (lower panel).
FANCD2 from multiple species (human, mouse, Fugu, 5B). IR failed to activate FANCD2 phosphorylation on
S222 in the AT cells, consistent with the role of ATMdata not shown) and is presumed to be functionally
relevant. Using the anti-pSer222 antibody, we analyzed kinase in the process. Phosphorylation of FANCD2 on
S222 was detected as early as 1 to 2 hr after IR exposurethe IR-activated phosphorylation of endogenous FANCD2
on S222 in wild-type versus AT lymphoblasts (Figure (Figure 5C) and was detected within an IR dose range
Cell
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Figure 4. In Vivo ATM-Dependent Phosphorylation of FANCD2 on S222 and S1404
(A) Schematic showing the full-length FANCD2 polypeptide and internally-truncated form FANCD2NcoI.
(B) Mobility change of FANCD2NcoI after IR treatment. Cell extracts from GM09607 (AT) stably infected with pMMP-puroFANCD2NcoI and
HeLa cells stably infected with pMMP-puroFANCD2NcoI were immunoblotted for FANCD2. Cells were treated with or without 30 Gy of IR,
as indicated, and 2 to 24 hr later, the cells were analyzed.
(C) Changes in mobility are due to changes in phosphorylation of FANCD2NcoI. Anti-FANCD2 immune complexes from cell extracts of
GM0637 cells stably infected with pMMP-puroFANCD2NcoI were treated with lambda-phosphatase as indicated and immunoblotted for
FANCD2.
(D) The phosphorylated FANCD2NcoI protein was purified from irradiated HeLa cells, trypsinized, and analyzed by mass spectrometry.
Two phosphotryptic fragments were identified. MS/MS spectrum of the phosphorylated FANCD2 tryptic peptide 196IM*QLISIA
PENLQHDIITSLPEILGD(pS)222QHADVGK229. The y7, y8, y13 and y14 product ions define the site of phosphorylation as S222. Methionine was
detected as the sulfoxide (M*).
(E) MS/MS spectrum of the doubly phosphorylated tryptic peptide 1393DLQGEEIKS1404SQNSQESTADESEDDMSSQASK1422. The spectrum was
complex but sufficient product ions were present to direct our studies to one phosphate at S1401 or S1404 (y22 and b13) and the second
phosphate C-terminal to E1413 (y9 and b21). Only one of the two phosphorylation sites (S1401) was verified in the current study.
(F) Summary of the two phosphorylated FANCD2 tryptic peptides observed by ion trap mass spectrometry.
of 5–20 Gy (Figure 5D). Also, in FA-A and FA-G (unubiquitinated) mutant form decreased the incorpora-
lymphoblasts, IR activated the phosphorylation of tion of [3H]-thymidine following IR exposure (Figures 6A
FANCD2-S, even though FANCD2 is not monoubiquiti- and 6C). FANCD2-S222A failed to restore the S phase
nated in these cells (Figure 5E). checkpoint, even though this mutant FANCD2 protein
was expressed at slightly higher levels (Figure 6B).
The IR-inducible, ATM-dependent phosphorylation ofATM-Dependent Phosphorylation of FANCD2 on
FANCD2 on S222 is therefore required for the establish-S222 Is Required for the IR-Inducible S Phase
ment of the S phase checkpoint. In contrast, theCheckpoint but Not the G1/S or G2/M Checkpoints
FANCD2 triple mutant (S1401A, S1404A, S1418A) had anWe next tested mutant forms of the FANCD2 protein
intermediate level of activity in this S phase checkpointfor their ability to establish the IR-inducible S phase
assay, with values between wild-type FANCD2 andcheckpoint (Figure 6). Stable transduction of FA-D2 fi-
broblasts with wild-type FANCD2 or the FANCD2-K561R S222A levels (data not shown). These data suggest that
Interaction of ATM and FANCD2
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Figure 5. Generation and Characterization of Anti-Phosphoserine Activation-Specific Antisera to S222 and S1404
(A) FA-D2 fibroblasts were stably transfected with either pMMP(empty vector), FANCD2(wt), FANCD2(S222A), FANCD2(triple mutant), or
FANCD2(quadruple mutant), as indicated. Cells were irradiated with 15 Gy, as indicated, and whole-cell lysates were immunoblotted with
either anti-pSer222, anti-pSer1404, or anti-FANCD2 antisera.
(B) The indicated lymphoblasts (PD7, WT; GM1526, AT) were irradiated with 15 Gy, as indicated, and immunoblotted with anti-pSer222
antibody.
(C) IR-activated phosphorylation of FANCD2 on S222 (time course). FA-D2 fibroblasts expressing either wild-type FANCD2 or FANCD2-S222A
were irradiated with 15 Gy. At the indicated times after irradiation, whole-cell lysates were immunoblotted with either the anti-pSer222 or anti-
FANCD2 antisera.
(D) IR-activated phosphorylation of FANCD2 on S222 (IR dose response). The PD20 transfectants were exposed to variable doses of IR as
indicated and evaluated for the phosphorylation of FANCD2 on S222 at 2 hr after irradiation.
(E) IR-activated phosphorylation of FANCD2-S on S222 in FA-A and FA-G lymphoblasts.
phosphorylation of S1404 is not as critical for the S checkpoint. In this respect, FA-D2 cells are more like
NBS cells which have a defect in the IR-inducible Sphase checkpoint response as phosphorylation at S222.
Whether ATM-dependent phosphorylation of serine res- phase checkpoint but a normal G2/M checkpoint (Xu et
al., 2002).idues other than S222 or S1404 affects this checkpoint
response remains unknown. We also analyzed FA-D2 cells for the function of the
G1/S checkpoint (data not shown). Uncorrected andWe next tested FA-D2 fibroblasts for the function of
the IR-inducible G2/M checkpoint (Figure 6D). Previous FANCD2-corrected FA-D2 EBV-transformed lympho-
blasts exhibited normal IR-inducible G1/S arrest andstudies have indicated that this checkpoint is defective
in ATM (/) cells (Zampetti-Bosseler and Scott, 1981; p53 induction (Kastan et al., 1991), indicative of a normal
G1/S checkpoint response in these cells.Morgan et al., 1997; Xu et al., 2001). Synchronized FA-
D2 or ATM (/) fibroblasts were irradiated in S phase, We next examined FA-D2 fibroblasts for clonogenic
survival following IR exposure (Figure 6E). Unlike FA-D2and their subsequent entry into mitosis was scored by
flow cytometry by measuring reactivity with MPM-2 anti- lymphoblasts (Figure 1C), FA-D2 fibroblasts exhibited
only a minor defect in clonogenic survival compared tobody (see Experimental Procedures). As previously de-
scribed, ATM (/) cells continued to enter mitosis after FANCD2 cDNA-corrected cells, and this defect was
more apparent in the higher IR dose range (6–8 Gy).2.0 Gy of IR (panel ii), resulting in a higher percentage
of mitotic cells, compared to ATM cDNA-corrected cells. We also tested fibroblasts from another FA comple-
mentation group (FA-C) for the IR-inducible S phaseIn contrast, PD20 (FA-D2) cells or those expressing
FANCD2, FANCD2-S222A, or FANCD2-K561R, exhib- checkpoint response (Figure 6F). Unlike FA-D2 cells, the
FA-C cells had a normal S phase checkpoint (i.e., littleited a normal IR dose-dependent delay in mitotic entry
(panel i). These results indicate that FA-D2 cells, unlike or no radioresistant DNA synthesis). Stable transduction
with the FANCC cDNA had no further effect on check-ATM (/) cells, have an intact IR-inducible G2/M
Cell
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Figure 6. ATM-Dependent Phosphorylation of FANCD2 on S222 Activates an IR-Inducible S Phase Checkpoint
(A) RDS assays. Radioresistant DNA Synthesis (RDS) was assessed 30 min after delivery of 10 Gy of IR to the indicated SV40 fibroblast lines.
(B) Whole-cell lysates from the indicated FA-D2 fibroblast transfectants were immunoblotted with polyclonal anti-FANCD2 antiserum to verify
expression level.
(C) IR dose-dependent RDS Assay of FA-D2 transfectants.
(D) FA-D2 cells have a normal IR-inducible G2/M checkpoint. The indicated SV40-transformed fibroblast lines were analyzed for the IR-
inducible G2/M checkpoint (see Experimental Procedures). The percentage of mitotic cells was measured from flow cytometric dot plots for
a mitotic marker (MPM-2) and DNA content. (i) PD20 (FA-D2) fibroblasts, expressing FANCD2, FANCD2-S222A, or FANCD2-K561R, or vector
alone, were analyzed for entry into mitosis after variable doses of IR. (ii) ATM (/) cells or ATM-corrected cells were evaluated for mitotic
entry after 2.0 Gy of IR. (iii) Examples are shown for PD20-vector (FA-D2) cells untreated (above) or treated with 2 Gy IR (below) at 16 hr
following release from double thymidine synchronization and treatment with taxol. Mitotic cells are identified by boxes.
(E) FA-D2 fibroblasts exhibit decreased clonogenic survival following IR. The indicated SV40-transformed fibroblast lines were plated at low
cell densities and irradiated. Surviving colonies were quantified after three weeks. Fractional cell survival is the number of colonies surviving
irradiation divided by the total colony number in an unirradiated parallel culture. Standard deviation is derived from three independent
experiments.
(F) RDS assay of FA-C SV40 transformed fibroblasts.
point activity but did complement the MMC sensitivity ing IR. Similarly, in cells expressing FANCD2-S222A, the
percentage of foci-positive cells increased from 17% toof the cells, as previously described (Strathdee et al.,
1992; Supplemental Table S1 available at http://www. 75% following IR.
The FANCD2-K561R mutant was not monoubiquiti-cell.com/cgi/content/full/109/4/459/DC1).
nated, as previously described (Garcia-Higuera et al.,
2001), but was phosphorylated on S222 following IRATM-Dependent Phosphorylation of FANCD2
Is Not Required for FANCD2 Nuclear Foci treatment (Figure 7B) consistent with its ability to correct
the S phase checkpoint. Taken together, these resultsFormation or MMC Resistance
We next analyzed the mutant forms of FANCD2 for mo- indicate that phosphorylation of FANCD2 on S222 is
not required for assembly of nuclear foci or for MMCnoubiquitination, FANCD2 nuclear foci formation, and
MMC resistance (Figure 7 and Supplemental Table S1 resistance.
available at above URL). Monoubiquitination of FANCD2
at K561 is required for targeting of FANCD2 to nuclear Discussion
foci and correction of MMC sensitivity (Garcia-Higuera
et al., 2001). In response to DNA damage, the wild-type FA-D2 Cells Are Sensitive to IR and Exhibit
Radioresistant DNA Synthesis (RDS)FANCD2 and FANCD2-S222A mutant (and the FANCD2-
triple mutant, data not shown) were monoubiquitinated, In the current report, we demonstrate that FA (subtype
D2) cells exhibit RDS, the hallmark of an IR-inducibleassembled into nuclear foci (Figure 7A), and corrected
the MMC sensitivity of FA-D2 cells (Figure 7C). S phase checkpoint defect. RDS has previously been
observed in cells derived from patients with other humanQuantification of the cells with FANCD2 foci indicated
that, in an unirradiated culture, only 18% of cells ex- diseases, including AT and NBS (Carney et al., 1998),
and ATLD (Stewart et al., 1999). BRCA1 (/) cells alsopressing wild-type FANCD2 showed 15 foci or more
(foci-positive). The percentage increased to 78% follow- exhibit RDS (Xu et al., 2001). In contrast to FA-D2 cells,
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Figure 7. Phosphorylation of S222 Is Not Required for Assembly of FANCD2 Foci
(A) PD-20F (FA-D2 fibroblasts) were stably transfected with either empty vector or the indicated vector expressing a wild-type or mutant
FANCD2 polypeptide. Cells were untreated or exposed to 10 Gy of IR, and after 8 hr, cells were fixed and immunofluorescence was performed
with a rabbit polyclonal anti-FANCD2 antiserum.
(B) Phosphorylation of the nonubiquitinated FANCD2(K561R) protein is detected by anti-pS222 antibody immunoblot.
(C) FANCD2(S222A) corrects the MMC sensitivity of FA-D2 cells.
(D) Schematic model of the ATM-BRCA1-FANCD2-mediated DNA damage response. The FANCD2 protein functions at the intersection of two
signaling pathways. IR activates ATM, resulting in the phosphorylation of FANCD2 (on S222) and several other protein substrates. These
phosphorylated proteins cooperate in an S phase checkpoint response. In addition, MMC activates the FA complex-dependent and BRCA1-
dependent monoubiquitination of FANCD2 (on K561), resulting in a DNA repair response.
cells derived from another FA subtype (FA-C) have a to IR. FA-D2 lymphoblasts are not as sensitive to IR as
AT lymphoblasts (Figure 1C), and based on clonogenicnormal S phase checkpoint.
Despite their defect in the IR-inducible S phase check- survival studies, FA-D2 fibroblasts have only a minor
IR sensitivity, compared to FANCD2 cDNA-correctedpoint, FA-D2 cells have only a minor cellular sensitivity
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fibroblasts (Figure 6E). The lack of correlation between point signal. Since the K561R mutant of FANCD2 acti-
vates the S phase checkpoint as efficiently as the wild-RDS and cellular IR sensitivity has been previously de-
scribed. NBS cells, for example, have a defect in the type protein, FANCD2 monoubiquitination and foci
formation are not required for this amplifier activity.IR-inducible S phase checkpoint but, like FA-D2 cells,
have only a minor IR sensitivity based on clonogenic Third, the IR-inducible S phase checkpoint is regulated,
at least in part, by the IR-dependent degradation ofsurvival assays in vitro (Xu et al., 2002; Girard et al.,
2000). The more pronounced IR sensitivity of AT cells cdc25A phosphatase (Falck et al., 2001). Degradation
of cdc25A results in persistent phosphorylation of cdk2may result from defects in other cell cycle checkpoints,
such as the G2/M checkpoint, or from defects in DNA and the normal inhibition of DNA replication following
IR. Preliminary studies indicate that IR-activated degra-repair.
Our observations are consistent with a model in which dation of cdc25A is normal in FANCD2 (/) cells, sug-
gesting that FANCD2 phosphorylation is unlikely to af-FANCD2 is a substrate of ATM and functions down-
stream of the FA protein complex (A/C/E/F/G complex; fect this process (K. Nakanishi and A.D.D, unpublished
data).see Figure 7D, model). Based on this model, we predict
that FA-D2 patients and Fancd2 knockout mice have a
more severe phenotype than other FA complementation Differential Activation of FANCD2 by
groups, with MMC sensitivity and IR sensitivity and with Monoubiquitination and Phosphorylation
clinical features of both FA and AT. Interestingly, while FANCD2 functions at the intersection of two signaling
only five FA-D2 patients have been identified to date, pathways (Figure 7D). In response to IR, ATM phosphor-
at least two of these patients have a more severe disease ylates FANCD2 on S222, resulting in the establishment
with phenotypic features of both FA (MMC sensitivity, of an S phase checkpoint. In response to MMC, the FA
skeletal abnormalities, and bone marrow failure) and AT protein complex and BRCA1 cooperate to regulate the
(immunodeficiency and lymphoma; A.D.D., unpublished monoubiquitination of FANCD2 on K561, resulting in
data). The relative degree of FA and AT phenotypic fea- MMC resistance (Garcia-Higuera et al., 2001).
tures of FA-D2 patients may result from hypomorphic These two posttranslational modifications and func-
alleles of FANCD2 expressing specific mutant FANCD2 tions of FANCD2 are dissociable. First, IR-dependent,
proteins with partial activity (Timmers et al., 2001). Simi- ATM-mediated phosphorylation of FANCD2 is indepen-
larly, Fancd2 knockout mice with a null allele (M. dent of FANCD2 monoubiquitination. Following IR,
Grompe, personal communication; Houghtaling et al., FANCD2-S phosphorylation occurs in FA cells of sub-
2001) exhibit a more severe phenotype (i.e., increased types A and G (and perhaps in FA cells from other sub-
MMC sensitivity and decreased testicular volume) com- types, such as C, E, and F), although FANCD2 is not
pared to Fanca (Cheng et al., 2000), Fancc (Chen et al., monoubiquitinated in these cells. Also, the K561R mu-
1996; Whitney et al., 1996), or Fancg (Yang et al., 2001) tant of FANCD2 is phosphorylated following IR and cor-
knockout mice. These observations further indicate a rects the S phase checkpoint, even though this protein
downstream role of the FANCD2 protein in the FA path- is not monoubiquitinated.
way (Figure 7D, model). The model predicts that primary Second, monoubiquitination of FANCD2 is indepen-
cells derived from Fancd2 (/) mice, but not from dent of FANCD2 phosphorylation on S222. FANCD2 mo-
Fanca (/), Fancc (/), or Fancg (/) mice, will noubiquitination and foci formation occurs in ATM (/)
have a defect in the IR-inducible S phase checkpoint. cells (Supplemental Table S1 available at http://www.
cell.com/cgi/content/full/109/4/459/DC1 and Figure
7D). These cells are defective in the S phase checkpointATM-Dependent Phosphorylation of FANCD2 Is
but are normally resistant to MMC. Inhibition of the ATMRequired for Activation of the S phase Checkpoint
kinase with wortmannin blocks FANCD2 phosphoryla-How the ATM-dependent phosphorylation of FANCD2
tion in normal cells but does not block DNA damage-establishes the IR-inducible S phase checkpoint re-
inducible monoubiquitination (data not shown). Themains unknown, and several models are possible. First,
phosphorylation-defective mutant form of FANCD2ATM phosphorylates other substrates contributing to
(FANCD2-S222A) is monoubiquitinated in response tothe S phase checkpoint, including Nbs1 (Gatei et al.,
DNA damage. While phosphorylation on S222 is not2000; Lim et al., 2000; Wu et al., 2000b; Zhao et al.,
essential for monoubiquitination, it is unknown whether2000), CHK2 (Ahn et al., 2000; Matsuoka et al., 1998,
phosphorylation of this residue, or some other residue,2000; Melchionna et al., 2000), and BRCA1 (Cortez et
may enhance FANCD2 monoubiquitination. Phosphory-al., 1999; Xu et al., 2001). These activated proteins may
lation primes the polyubiquitination of many protein sub-physically interact with phosphorylated FANCD2 in a
strates (Ciechanover et al., 2000), but the effect on pro-checkpoint protein complex. Such a multisubunit com-
tein monoubiquitination remains unknown.plex may act as a sensor of damaged DNA and may
bind and locally inhibit DNA replication. Consistent with
this model, Nbs1 (Paull and Gellert, 1999), BRCA1 (Paull Activation of DNA Repair and MMC Resistance
by Monoubiquitination of FANCD2et al., 2001), and FANCD2 (Garcia-Higuera et al., 2001)
associate with chromatin. Also, Nbs1 promotes the How MMC-activated, FA complex-dependent mono-
ubiquitination of the FANCD2 protein at K561 regulatesATM-dependent phosphorylation of FANCD2 after IR
exposure (K. Nakanishi and A.D.D, unpublished data) MMC resistance remains unknown. Monoubiquitination
at K561 is required for targeting of the FANCD2 proteinconsistent with a physical interaction among these pro-
teins. Second, the ATM-dependent phosphorylation of to BRCA1 foci (Garcia-Higuera et al., 2001) and RAD51
foci (R.C.G. and A.D.D., unpublished data), and theseFANCD2 may function as a signal amplifier of the check-
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(Nakanishi et al., 2001), PD20 fibroblast (Jakobs et al., 1996),nuclear foci form during normal S phase of the cell cycle
AT22IJE-T fibroblasts, and AT22IJE-T expressing either empty vec-and following DNA damage. Since BRCA1 and RAD51
tor or full-length ATM (Ziv et al., 1997) were described previously.are required for homology-directed DNA repair (HDR;
EBV-transformed lymphoblasts (HSC72, FA-A; EUFA316, FA-G;
Moynahan et al., 1999; Pierce et al., 1999; Baumann and PD7, wild-type; GM1526, AT) were maintained in RPMI with 15%
West, 1998), the FA pathway may also regulate HDR FCS. Gamma irradiation was delivered using a Gammacell 40 appa-
ratus.activity. Consistent with this model, FA-D2 cells have a
minor defect in homologous recombination repair, which
Retroviral Infectioncan be corrected by wild-type FANCD2 but not by the
Production of pMMP retroviral supernatants and infection of fibro-K561R mutant protein (T.T., unpublished data).
blasts were done as previously described (Naf et al., 1998). After
The precise role of monoubiquitinated FANCD2 in ho- 48 hr, cells were trypsinized and transferred to medium containing
mologous recombination repair also remains unknown. puromycin (1 g/ml). Dead cells were removed and surviving cells
Monoubiquitinated FANCD2 may play a role in sensing were grown under continuous selection in puromycin.
DNA crosslinks, in allowing the homologous recombina-
Generation of Anti-Phosphoserine Antibodiestion machinery (including BRCA2 and RAD51; Davies et
For the generation of anti-pS-222 and anti-pS-1404 antisera, rabbitsal., 2001) to assemble at sites of DNA damage, or in
were immunized with a KLH (keyhole limpet hemocyanin)-conju-regulating the fidelity of recombination. The identifica-
gated FANCD2 phosphopeptide (EILGDpSQHAD) or phosphopep-
tion of other proteins which bind to monoubiquitinated tide (KSQNpSQEST), derived from amino acids 217 to 226 or 1400
FANCD2 or the cloning of other FA genes, such as to 1408 of FANCD2, respectively. The resulting antisera were affinity-
FANCB or FANCD1 (Grompe and D’Andrea, 2001), may purified by binding to and elution from a column containing the
corresponding phosphopeptide antigen. Antibodies directedprovide additional insights to the role of the FA pathway
against nonphosphospecific epitopes were subsequently removedin HDR.
from the eluate by passing it over a column containing the corre-
sponding nonphosphorylated peptide.
Ataxia Telangiectasia and Fanconi Anemia
Are Clinically Distinct Immunoblotting
In addition to their common phenotypic characteristics Cells were lysed with 1 sample buffer (50 mM Tris-HCl [pH 6.8],
86 mM 2-mercaptoethanol, and 2% sodium dodecyl sulfate [SDS]),and hematologic cancer susceptibility, AT and FA have
boiled for 5 min, and subjected to 7.5% polyacrylamide SDS geldistinct phenotypic differences (Khanna et al., 1999). AT
electrophoresis. After electrophoresis, proteins were transferred topatients have immunodeficiency, sinopulmonary infec-
nitrocellulose membrane using a submerged transfer apparatustions, and progressive cerebellar neural degeneration,
(BioRad), filled with 25 mM Tris base, 200 mM glycine, and 20%
while FA patients have multiple developmental abnor- methanol. After blocking with 5% nonfat dried milk in TBS-T (50
malities and bone marrow failure. Our results explain, mM Tris-HCl [pH 8.0], 150 mM NaCl, and 0.1% Tween 20) the mem-
brane was incubated with the primary antibody diluted in TBS-Tat least in part, the molecular basis of these phenotypic
(1:200 dilution for the anti-FANCD2 mouse monoclonal antibodydifferences. AT cells are primarily sensitive to IR, while
FI17 [Garcia-Higuera et al., 2001], and at 1 g/ml for anti-p95NBS1FA cells are primarily sensitive to crosslinking agents.
polyclonal antibody [Ab-1, Oncogene Research Products]), washedATM phosphorylates not only FANCD2 but also a wide
extensively and incubated with the appropriate horseradish peroxi-
range of other protein substrates required for normal dase-linked secondary antibody (Amersham). Chemiluminescence
development. The monoubiquitination of FANCD2, and was used for detection.
perhaps other substrate proteins, appears to be re-
Immunoprecipitation and Phosphatase Treatmentquired for cellular and developmental processes, which
Whole-cell extracts were prepared in lysis buffer (50 mM Tris-HClare specifically defective in FA patients.
[pH 7.4], 150 mM NaCl, and 1% (v/v) Triton X-100) supplemented
with protease inhibitors (1 g/ml leupeptin and pepstatin, 2 g/mlExperimental Procedures
aprotinin, and 1 mM phenylmethylsulfonylfluoride) and phosphatase
inhibitors (1 mM sodium orthovanadate and 10 mM sodium fluoride).Plasmids
Using the polyclonal antibody to FANCD2 (E35), immunoprecipita-The retroviral expression vector, pMMP-puro (Ory et al., 1996),
tion (IP) was performed essentially as described (Garcia-Higuera etpMMP-puro FANCD2 wt, and pMMP-puro FANCD2(K561R) (Garcia-
al., 2001). Each FANCD2 IP (normalized to contain 2 mg of protein)Higuera et al., 2001) were described previously. FANCD2 cDNA has
was washed twice in lambda phosphatase buffer (New Englandinternal NcoI sites at nt872 and nt1739 of its open reading frame.
Biolabs) and resuspended in 50 l of lambda phosphatase bufferThe FANCD2NcoI was generated by deletion of the internal NcoI
either in the presence or absence of the phosphatase inhibitors,restriction fragment from the FANCD2 open reading frame. The
NaF (50 mM) and sodium orthovanadate (2 mM). Five hundred unitsFANCD2NcoI cDNA was ligated into pcDNA3.1(-) (Invitrogen) or
of lambda-phosphatase (New England Biolabs) was added to eachpMMP-puro. For constructing pGEX-FANCD2(2-272), pGEX-
sample, followed by incubation at 30C for 1 hr. Samples were sepa-FANCD2(268-575), pGEX-FANCD2(570-880), pGEX-FANCD2(875-
rated by 7% SDS-PAGE and immunoblotted for FANCD2 using FI171190), pGEX-FANCD2(1186-1451), and pGEX-FANCD2(190-249),
antibody.PCR products of corresponding fragments were ligated to the
EcoRI/XhoI sites of the plasmid pGEX4T-1 (Pharmacia). The K561R,
Immunofluorescence MicroscopyS222A, S1257A, S1418A, S1401A-S1404A(double), S1401A-
Indirect immunofluorescence microscopy with the polyclonal anti-S1404A-S1418A(triple), and S222A-S1401A-S1404A-S1418A(qua-
FANCD2 antiserum was performed as previously described (Garcia-druple) mutant FANCD2 cDNAs were produced with the QuikChange
Higuera et al., 2001).site-directed mutagenesis kit (Stratagene). The cDNA inserts were
verified by DNA sequencing.
Mass Spectrometry
HeLa cells stably infected with pMMPpuroFANCD2NcoI wereCell Culture
The SV40-transformed fibroblasts, GM0637(normal), 326SV(FA-G), treated with 30 Gy of ionizing radiation and 2 hr later, whole-cell
extracts were prepared in lysis buffer. IP was performed using puri-PD426(FA-C), PD20(FA-D2), GM09607(AT) as well as HeLa cells,
were grown in DMEM supplemented with 15% FCS. GM0637 and fied monoclonal antibody against FANCD2 (FI17) and the IP product
was separated by 7% SDS-PAGE. Gel pieces corresponding toGM09607 were purchased from Coriell Cell Repositories. FAG326SV
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FANCD2NcoI bands were cut from a Coomassie stained gel and from the second thymidine block and then grown in 2.5 microgram/
ml taxol for 16 hr to trap mitotic cells. Cells were collected bysubjected to S-carboxyamidomethylation and tryptic digestion. Mul-
tiple peptide sequences were determined in a single run by 75 m trypsinization, pooled with nonattached cells, and fixed for 10 min
with 90% methanol/PBS at –20C. Incubation with MPM-2 antibod-LD microcapillary reverse-phase chromatography directly coupled
to a ThermoFinnigan LCQ DECA quadrupole ion trap mass spec- ies (Dako, Carpenteria, CA) and with secondary antibodies to detect
mitotic cells, and incubation with propidium iodide were as pre-trometer equipped with a custom nanoelectrospray source. MS/MS
spectra were acquired with a relative collision energy of 30%, an viously described (Andreassen and Margolis, 1994; Andreassen et
al., 2001). Cells were analyzed with a FACSCalibur system (Becton-isolation width of 2.5 Da, and recurring ions dynamically excluded.
Interpretation of the resulting MS/MS spectra of the peptides was Dickinson) using Cell Quest Software. Cell aggregates were gated
out and 10,000 events were analyzed. For all cell lines tested, thefacilitated using the program FuzzyIons developed in the Harvard
Microchemistry Facility and by database correlation with the algo- percent mitotic cells after 16 hr in taxol was approximately 70%
(5%). The percent mitotic cells collected at each dose of IR wasrithm SEQUEST.
calculated relative to the number of mitotic cells in unirradiated
controls for each cell type.ATM-Dependent In Vitro Kinase Experiments
Several GST-FANCD2 constructs spanning the full-length FANCD2
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